MRFR Year End Sale
Automated Cell Culture Market Research Report - Forecast till 2027

Automated Cell Culture Market: Information by Type (Modular Automation and Whole Lab Automation), Product (Consumables and Vessels), Application (Biopharmaceutical Production, Diagnostics, Gene Therapy, Drug Screening and Development, Toxicity Testing, Stem Cell Research, Tissue Engineering & Regenerative Medicine) and Region (Americas, Europe, Asia-Pacific and Rest of the World) - Forecast till 2027

ID: MRFR/LS/0283-CR | July 2020 | Region: Global | 148 Pages         

Automated Cell Culture Market

The Automated Cell Culture Market touched a value of USD 8,579.8 million and was expected to project a CAGR of 8.18% during the 2020-2027 forecast period


By Type Whole Lab Automation Modular Automation
By Product Vessels Consumables
By Application Diagnostics Biopharmaceutical Production Toxicity Testing Drug Screening and Development Tissue Engineering and Regenerative Medicine Stem Cell Research
By End-user Hospital and Diagnostic Laboratories Pharmaceuticals and Biotechnology Companies Cell Banks Research Institutes

Key Players

  • Tecan Trading AG (Switzerland)
  • Siemens Healthcare GmbH (Germany)
  • F. Hoffmann-La Roche (Switzerland)
  • Hitachi Ltd (Japan)
  • Beckman Coulter Inc. (US)
  • Thermo Fisher Scientific (US)
  • Hamilton Company (US)
  • Sartorius Stedim Biotech Group (Germany)
  • Becton
  • Dickinson


  • Advancement in the development
  • Increase the lucrativeness of investing in the development
  • Delivering gene therapies for genetic diseases
Speak to Analyst Request a Free Sample

Automated Cell Culture Market Overview:

In 2019, the automated cell culture market touched a value of USD 8,579.8 million and was expected to project a CAGR of 8.18% during the 2020-2027 forecast period.

The primary use of automated cell culture systems is in the laboratories engaged in functions like cell signaling, protein expressions, drug discovery, and similar operations. These systems help in avoiding the errors caused by technicians and also help in saving time. It is indeed a wonderful tool for studying human diseases. But there is a lack of awareness about the procedure. Human resources with skills to or on the systems also lack, which has been a challenge in the automated cell culture market size growth.

Various factors have proved to be responsible for the growth of the automated cell culture market. Development and research in stem cells, drug discovery, and increased investments towards developing novel products are among a few of them. Other factors include the increased production of vaccines and gene therapy. Not just this, the advancement in complex bioreactors and spheroid have also bought a bacterial cell culture market growth.

COVID-19 analysis

COVID-19 pandemic has brought about the worst time for every living being on this planet. Physical, mental, and financial stress is getting out of control while we know, there is nothing much we can do to ensure the pandemic would get over soon; apart from the precautions, we can surely take into consideration the changes we can bring about in our lives to adjust with the current situation. The pandemic is not over yet, and there is no clue when it would be, so the better thing to do is to make changes in our working pattern and work culture. All this needs the help of trained analysts and industry experts. The reports provided to the companies have updated information about the market. These necessary steps need to be taken for a safe future and to combat the past losses.

Market dynamics

While the automated cell cultures provide improved quality of cell lines and the increased productivity, they also ensure no change in the process. Automated cell culture in various areas like biopharmaceutical productions, gene therapy, diagnostics, development, and screening of drugs, stem cell research, toxicity testing, tissue engineering, and regenerative medicine has given a push to the automated cell culture market towards the growing trend.

On the other hand, there are factors like lack of skilled labor for the operations and lack of awareness about the procedure that has led to the market's pull-back growth. Acquisitions by the major players in the. The automated cell culture market analysis has led to the broadening of the horizons in the global economy and expanded the market's reach across the globe. The fluctuating prices of consumables have also led to the hampered growth of the automated cell culture market trend during the pandemic.

Regulatory implications

The automated cell culture system market has not been facing many challenges as far as the regulations and laws are concerned. This is because the procedures that are used in the automated cell culture market are eco-friendly and there is nothing involved in destroying the environment. Moreover, because these are genes and cell-based processes, they do not pose any harm to human life as well. Therefore, their use and applications in various fields have proved as a blessing for medical work. Not just because of their use in the field of pharmaceuticals but also because it's great to use to treat chronic diseases like cancer.

Segmentation overview

The automated cell culture market is broadly classified into four segments:

  1.     Based on the type

  2.     Based on product

  3.     Based on the application

  4.     Based on the end-user

Based on the type: Based on the type, the meet can be unclassified into the following categories:

  1.     Whole lab automation

  2.     Modular automation

The modular automation segment dominates the automated cell culture market, with a share of 67.1% in the market.

Based on the product: Based on the product, the market is subdivided into the following:

  1.     Vessels

  2.     Consumables

The consumables segment dominates the automated cell culture market with a share of almost 67%.

Based on the application: Based on the application, the market can be classified into the following:

  1. Diagnostics

  2. Biopharmaceutical production

  3. Toxicity testing

  4. Drug screening and development

  5. Tissue engineering and regenerative medicine

  6. Stem cell research

The biopharmaceutical segment dominates the market with a share of around 22.1%.

Based on the end-user: Based on the end-user, the market can be further divided into:

  1.     Hospital and diagnostic laboratories

  2.     Pharmaceuticals and biotechnology companies

  3.     Cell banks

  4.     Research institutes.

Pharmaceutical and biotechnology companies dominate the market.

Regional analysis

Based on the regions, the market is divided into the following:

  • Europe

  • Americas

  • Asia pacific

  • The Middle East and Africa

America dominates the automatic cell imaging system market because most of the major players are located in the region. In the year 2019, it accounted for almost 42% share in the automated cell culture market size. The growth of the market in Europe is also expected to take a steep rise due to the increased presence of manufacturers and the rise in chronic diseases. The Asia Pacific is also expected to witness fast bacterial cell culture market growth because of the increase in the geriatric population, increased ontological problems, and an increase in the healthcare system quality. The Middle East and Africa have been witnessing many new partnerships, leading to the market's growth. Also, the present medical tourism and cell banks have created a great demand for the bacterial cell culture market size.

Competitive landscape

The major players in the automated cell culture system market include Tecan Trading AG (Switzerland), Becton, Dickinson, and Company (the US, Siemens Healthcare GmbH (Germany), F. Hoffmann-La Roche (Switzerland), Hitachi, Ltd (Japan), Beckman Coulter, Inc. (the US), Thermo Fisher Scientific (US), Hamilton Company (US) and Sartorius Stedim Biotech Group (Germany).

All these major players in the automated cell culture market have made a name for themselves by following the strict plans and strategies and implementing them religiously. Also, various acquisitions, collaborations, and mergers have led to the market's growth to a great extent.

Recent advancements

  1.     In May 2019, the Ambr 15 cell culture was launched by Sartorius AF, an automatic micro bioreactor system.

  2.     Fluent Gx automation workstation was launched by Tecan trading group AG Switzerland which is used in regulated laboratories. It helps in providing flexibility for the laboratory needs like next-generation sequencing, clinical diagnostics, and nucleic acid purification. It has led to the expansion of cloning selection capability.

  3.     In July 2017, technology was launched to report and release urine future negative reports automatically. It was launched by Becton, Dickinson, and the company.

  4.     The approvals that these products are getting on different levels have made the automated cell culture industry trend grow at a fast pace.

  5.     In May 2019, the acquisition of Brammer bio was completed by Thermo Fischer Scientific Inc to increase the vector manufacturing for cell and gene therapies. 

Report overview

The report prepared for the companies has everything that they would need for smooth functioning even after the pandemic. It includes the market overview and the automated cell culture market analysis in the corona period. It also has the market dynamics report, which includes the factors responsible for growth as the factors that hamper the growth of the market.

Also, the segmentation of the market cases on the type, application, product, end-user, and regions is described in the report. The key advancements in the market and the major players operating in the market are also included and can't provide self-analyzing deals for the companies to work according to the present scenarios. While they realize the things they lack behind in, they are also provided proper guidance and mentorship by the experts and the industry analysts about various steps that can be taken to properly function. The qualitative and the quantitative aspects of the market were also studied properly by the experts and then discussed in the detailed report provided to the organizations. These help the organization self-introspect themselves and understand the limitations they try to have, and work in them accordingly.

Report Scope:

Report Attribute/Metric Details
  Market Size   2027: USD 8,579.8 Million
  CAGR   CAGR of 8.18% (2020-2027)
  Base Year   2020
  Forecast Period   2027
  Historical Data   2019
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors and Trends
  Segments Covered   Type, Product, Application and End User
  Geographies Covered   North America, Europe, Asia-Pacific and Rest of the World (RoW)
  Key Vendors   Tecan Trading AG (Switzerland), Siemens Healthcare GmbH (Germany), Hitachi, Ltd (Japan), Thermo Fisher Scientific (US), Sartorius Stedim Biotech Group (Germany), Hamilton Company (US), Beckman Coulter, Inc. (US), F. Hoffmann-La Roche (Switzerland), Becton, Dickinson
  Key Market Opportunities   Increase in product approvals
  Key Market Drivers

  • Advancement in the development
  • Increase the lucrativeness of investing in the development
  • Delivering gene therapies for genetic diseases

  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    Lack of technical knowledge and expertise and high value of the machines could prevent the market from growing with the expected growth rate.

    The end user is academic institutes, research organizations, biotech companies, and others.

    The major consumables discussed are media, sera, and reagents.

    The types included are finite cell line cultures and infinite cell line cultures.